Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
8.56M
-
Shares change
-
+955K
-
Total reported value, excl. options
-
$704M
-
Value change
-
+$78.9M
-
Put/Call ratio
-
0.86
-
Number of buys
-
101
-
Number of sells
-
-60
-
Price
-
$82.20
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2019
213 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2019.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.56M shares
of 22.3M outstanding shares and own 38.42% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.43M shares), VANGUARD GROUP INC (564K shares), MANGROVE PARTNERS (549K shares), DIMENSIONAL FUND ADVISORS LP (537K shares), NOMURA HOLDINGS INC (375K shares), DEUTSCHE BANK AG\ (317K shares), FIRST MANHATTAN CO (295K shares), STATE STREET CORP (289K shares), RENAISSANCE TECHNOLOGIES LLC (288K shares), and INVESTMENT COUNSELORS OF MARYLAND LLC (280K shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.